MODERN APPROACHES TO THE DIAGNOSIS AND TREATMENT OF MIXED ANXIETY-DEPRESSIVE DISORDERS IN PRIMARY HEALTH CARE
DOI:
https://doi.org/10.31082/1728-452X-2020-215-216-5-6-53-62Keywords:
depression, anxiety, primary health care, general medical practice, antidepressantsAbstract
The relevance of this work is due to the wide prevalence of mixed anxiety-depressive disorders among general medical practice patients. At the present stage of development of the psychiatric service in the Republic of Kazakhstan, a new concept has been developed that assumes the transfer of a number of borderline mixed anxiety-depressive disorders to the competence of PHC doctors with the need for their treatment with modern antidepressants.
The purpose of this work. Development and implementation in general clinical practice of modern methods of diagnosis and treatment of mixed anxiety-depressive disorders.
Material and methods. 30 patients with mixed anxiety-depressive disorders of the borderline level, who were treated on an outpatient basis (Nursultan) was examined. The study was conducted using international psychometric scales: Hospital Anxiety and Depression Score (HADS), Hamilton Anxiety and Depression Rating Scale (HDRS, HAM-A).
Results and discussion. As a result of the study, it was found that among patients with mixed anxiety-depressive disorders who were treated on an outpatient basis, young people of working age from 21 to 50 years (83.3%) prevailed, in whom psychogenic anxiety-depressive disorders accounted for 60%.
In the course of clinical observations, objective data were obtained indicating that when treating depressive states of mild and moderate severity with Mianserin drug on an outpatient basis, by the end of the second week of treatment, there is a fairly pronounced positive dynamics in the reduction of symptoms of depression. By the end of the second month of taking this drug (8 weeks), most patients had no symptoms of depression.
Conclusions. Practical clinical observations have shown that the modern Mianserin antidepressant, possessing a wide range of clinical effects combining thymoanaleptic action proper with anti-anxiety, sedative and hypnotic effects is well tolerated by patients and can be recommended for widespread use in the treatment of mixed anxiety-depressive disorders in general medical practice.
References
Mosolov SN, Kostyukova EG, Ushkalova AV. Clinical picture and therapy of bipolar depression. Moscow: AMA-Press, 2010. 48 p.
Smulevich A.B. Depression in mental and somatic diseases. - 4th ed., Revised and enlarged. Moscow: MIA, 2015. 640 p.
Belialov FI. Depression, anxiety, stress and mortality. Terapevticheskii arkhiv = Therapeutic archive. 2016;12:116-119.
(In Russ.)
Zakharov VV. Late-life depression. Farmateka = Pharmateca. 2016;7(320): 6-13. (In Russ.)
Kalyn YaB, Gavrilova SI, Safarova TP, et al. New opportunities for optimizing the treatment of depression in gerontopsychiatric practice. Farmateka = Pharmateca. 2016; s4:46-54. (In Russ.)
Dolmatova EU, Mitchenko NV, Nazarkona AS, Usova EN. Features of counseling and psychocorrection of depression in elderly people. Biulleten meditsinskikh internet-konferentsii = Bulletin of Medical Internet Conferences. 2015;5(12):1704-1705. (In Russ.)
Ivanets NN, Kinkulkina MA, Avdeeva TI, et al. The efficacy of psychopharmacotherapy of late onset depression: the optimization of treatment duration. Zhurnal nevrologii I psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2016;4:16-27. (In Russ.). DOI: 10.17116/jnevro20161164116-27
Kuchkorov UI, Mukhtorova HC, Zharylkasynova GZh, Giyosova NO. The syndrome of depression in general medical practice. Zhurnal «Spravochnik vracha obshchei praktiki» = Journal "Directory of General Practitioner". 2015;2:48-51. (In Russ.)
Khalilova UA, Skvortsov VV, Skvortsov KY. Depressive disorders in cardiac patients and their correction with sertraline (Zoloft). Poliklinika = Polyclinic. 2016;5-1: 36-39. (In Russ.)
Baranov AP, Strutynskiy AV, Oynotkinova OSh, et al. Possibilities of anxiety-depressive disorders treatment in patients with chronic heart failure. Rossiiskii kardiologicheskii zhurnal = Russian Journal of Cardiology. 2017;1(141):128-135. (In Russ.). DOI: 10.15829/1560-4071-2017-1-128-135
Voronova EI, Dubnitskaya EB. Reactive (psychogenic) depression. Zhurnal nevrologii I psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2015;2:75-85
(In Russ.)
Marachev MP. Difficulties in treating depression in comorbid conditions (based on the 24th EPA Congress, March 2016). Psikhiatriia i psikhofarmakoterapiia = Psychiatry and psychopharmacotherapy. 2016;2:62-66(In Russ.)
Turaev BT, Ochilov UU, Kubaev R.M. Distribution of anxiety and depression in affective disorders of somatized depression. MEDICUS, "Izdatelstvo "Nauchnoe obozrenie" (Volgograd) = MEDICUS, "Scientific Review" Publishing House (Volgograd). 2020;3(33):58-60. (In Russ.)
Abzalova RA. On the model of psychiatric care in primary health care. Sbornik materialov IV Sieezda psikhiatrov, psikhoterapevtov, narkologov i meditsinskikh psikhologov Respubliki Kazakhstan (s mezhdunarodnym uchastiem): «Integratsiia sluzhby psikhicheskogo zdorovia i pervichnoi mediko-sanitarnoi pomoshchi» 21-22 avgusta 2014 goda (Prilozhenie). Astana, 2014. p. 3-7. Collection of materials of the IV Congress of Psychiatrists, Psychotherapists, Narcologists and Medical Psychologists of the Republic of Kazakhstan (with international participation): "Integration of mental health services and primary health care" August 21-22, 2014 (Appendix). Astana, 2014. p. 3-7
Ivanets NN, Kinkulkina MA, Avdeeva TI, Izyumina TA. The possibility of using standardized self-report anxiety and depression scales in elderly patients: anxiety scales/questionnaires. Zhurnal nevrologii I psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2016;10:51-59. (In Russ.)
BNF 76 (British National Formulary) September 2018 - March 2019. Tricyclic antidepressants. 367 p.
Riemann D, Baglioni C, Bassetti C. Bjorvant B, et al. European guideline for the diagnosis and treatment of insomnia.
J. SleepRes. 2017;26(6):675-700. DOI: 10.1111/JSR.12594
Ushkalova AV, Ushkalova EA. Current recommendations for pharmacotherapy of acute episodes of bipolar depression. Farmateka = Pharmateca. 2015;s3-15: 26-32. (In Russ.)
Psareva NA, Kukes VG, Kazakov RE, et al. Pharmacotherapy of depression from the perspective of personalized medicine. Klinicheskaia farmakologiia i terapiia = Clinical pharmacology and therapy. 2015;3:62-65. (In Russ.)
